Meros Investment Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,454
Closed -$688K 53
2025
Q4
$688K Sell
28,454
-18,156
-39% -$475K 0.27% 46
2025
Q3
$1.19M Sell
46,610
-105,077
-69% -$2.49M 0.51% 34
2025
Q2
$3.27M Buy
151,687
+20,037
+15% +$452K 1.55% 30
2025
Q1
$3.01M Sell
131,650
-33,795
-20% -$890K 1.77% 27
2024
Q4
$4.29M Sell
165,445
-8,465
-5% -$211K 1.92% 27
2024
Q3
$4.35M Sell
173,910
-225,893
-57% -$5.34M 1.97% 23
2024
Q2
$8.57M Buy
399,803
+6,586
+2% +$128K 4.05% 8
2024
Q1
$7.29M Buy
393,217
+999
+0.3% +$17.5K 3.26% 11
2023
Q4
$6.37M Buy
392,218
+20,015
+5% +$255K 3.02% 14
2023
Q3
$5.14M Buy
372,203
+47,724
+15% +$752K 2.8% 18
2023
Q2
$7.17M Buy
324,479
+99,711
+44% +$2.1M 3.56% 11
2023
Q1
$4.89M Buy
224,768
+8,649
+4% +$195K 2.78% 15
2022
Q4
$3.93M Buy
216,119
+73,261
+51% +$1.51M 2.32% 23
2022
Q3
$3.25M Sell
142,858
-55,780
-28% -$1.19M 3.35% 11
2022
Q2
$2.74M Buy
198,638
+150,134
+310% +$2.2M 2.54% 17
2022
Q1
$1.1M Buy
48,504
+23,009
+90% +$606K 0.87% 30
2021
Q4
$950K Buy
+25,495
New +$1.09M 0.69% 36

Other funds holding BLFS

Meros Investment Management's BLFS Position: Q1 2026 in Review

Meros Investment Management sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 28,454 shares — an estimated $688K sold.

Meros Investment Management first reported a position in BLFS in Q4 2021 and held it in 17 quarters. The position peaked at $8.57M in Q2 2024. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Meros Investment Management reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
  • Meros Investment Management sold 28,454 BioLife Solutions shares in Q1 2026, an estimated $688K.
  • Meros Investment Management first reported a position in BioLife Solutions in Q4 2021 and held it in 17 quarters.
  • Meros Investment Management's BioLife Solutions position peaked at $8.57M in Q2 2024.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Meros Investment Management's 13F filing for Q1 2026, filed 14 May 2026.